Today's Healthcare Pulse
FDA greenlights durvalumab combo for high‑risk bladder cancer
The FDA approved durvalumab (Imfinzi) combined with Bacillus Calmette‑Guerin for BCG‑naïve, high‑risk non‑muscle invasive bladder cancer. The POTOMAC trial enrolled 1,018 patients and showed a 32% reduction in disease recurrence risk (hazard ratio 0.68, p=0.015). Durvalumab is given at 1,500 mg IV every four weeks for up to 13 cycles.
Also developing:
By the numbers: Apogee Therapeutics raises $1.3B royalty financing
I Sold My Startup A Year After Founding It. Here’s Why That Was The Fastest Way To Build Real-World Healthcare...
Louis Blankemeier co‑founded Cognita to turn Stanford‑level radiology AI into a clinical product. Within a year, the team sold the startup to Radiology Partners, the world’s largest radiology practice, to gain scale, data access, and regulatory pathways. The acquisition enables continuous radiologist feedback, rapid model refinement, and evidence generation across a national network. Blankemeier argues that joining an established system is the fastest route to real‑world healthcare impact.
Facing Alzheimer's Fear, Patients Say Yes to Blood Tests
A new Northwestern Medicine survey of nearly 600 primary‑care patients revealed that 85% would agree to an Alzheimer’s blood‑based biomarker test if their doctor recommended it. While 84% of respondents were previously unaware of such tests, brief education raised acceptance...
Attention Turns To UnitedHealth Earnings For Signs Of Insurer Rebound
UnitedHealth Group is set to release its first‑quarter earnings, offering the market a first look at how the nation’s largest health insurer is coping with soaring medical costs. Industry medical loss ratios have surged above 90%, far higher than the...
Medical Debt Drives Suicide, Not Patient Non‑Compliance
Sixteen percent of suicides in the United States have medical debt as a contributing factor. We talk about patient non-compliance in medicine as if it is a behavioral problem. For a significant number of patients, it is a financial one....
Dr. Marlow Hernandez: Patients Are Heroes—But Our Healthcare System Doesn’t Always Treat Them That Way
Dr. Marlow Hernandez argues that labeling patients as heroes is meaningful only when healthcare systems back the terminology with concrete actions. He highlights persistent gaps—delayed follow‑up, fragmented communication, and lack of continuity—that undermine patient dignity despite well‑intentioned language. Hernandez calls...
MedjetHorizon Gets You Out of Trouble (Sponsored Post)
Medjet has expanded its flagship medical evacuation membership with MedjetHorizon, a security‑focused add‑on that provides 24/7 global crisis response. The service assists travelers facing violent incidents, civil unrest, natural disasters, and even disappearance, coordinating with police, consulates, and evacuation providers....
Texas A&M Nasal Spray Reverses Brain Aging in Preclinical Study
Researchers at Texas A&M University, led by Dr. Ashok Shetty, showed that a two‑dose extracellular‑vesicle nasal spray eliminated neuroinflammation and restored memory in aged rodents. The preclinical results, published in the Journal of Extracellular Vesicles, suggest a non‑invasive route to...
Japanese Medical Devices Firm Create Medic Plans to Expand India Operations
Japanese medical‑device maker Create Medic announced a major push into India, opening a dedicated sales office in Chennai and planning similar hubs in Delhi, Kolkata and Ahmedabad. The firm is targeting roughly ₹100 crore (about $12 million) in annual revenue from the...
FDA Grants Priority Review to Daiichi Sankyo, Merck’s B7‑H3 ADC for Small‑Cell Lung Cancer
The U.S. Food and Drug Administration has placed Daiichi Sankyo and Merck’s ifinatamab deruxtecan (I‑DXd) on its Priority Review list for extensive‑stage small‑cell lung cancer (ES‑SCLC) that progressed after platinum chemotherapy. The agency set an October 10 2026 decision deadline and will...
Top Strategies to Improve Medical Practice Operations
Medical practices are increasingly hamstrung by ad‑hoc operational processes that lag behind clinical growth, leading to scheduling chaos, billing denials, and staff burnout. A JAMA Network study shows administrative costs consume 15‑20% of U.S. healthcare spending, underscoring the financial drag....
QIAGEN Launches QIAstat-Dx BCID GPF Plus AMR Panel for Bloodstream Infection Syndromic Testing
QIAGEN has launched the CE‑IVDR‑certified QIAstat‑Dx BCID GPF Plus AMR Panel for rapid bloodstream‑infection syndromic testing. The assay detects 20 gram‑positive bacterial and fungal targets and ten antimicrobial‑resistance markers, delivering results in approximately one hour. Announced at the ESCMID Global...
J&J Targets $100B Revenue, Replimune Rebuffed Again and a “Revolution” In Pancreatic Cancer
Johnson & Johnson reported $24.1 billion in first‑quarter sales and set an ambitious $100 billion revenue target for 2026, underscoring its aggressive growth strategy amid a wave of biotech M&A. Replimune’s advanced melanoma therapy RP1 was denied again, with the FDA insisting...
Strength Training Beats Pills, Injections, Surgery for Knee OA
Knee Osteoarthritis: Thread Number 3 The most powerful intervention for knee osteoarthritis is not a pill, not an injection, and not a surgery. It's not PRP and certainly not stem cells. It is the muscle above and below the joint. If you...
How to Select a Healthcare Software Vendor (Without the Headaches)
Healthcare startups often select offshore software vendors lacking deep clinical expertise, leading to costly delays and compliance failures. A recent case described a Series‑A startup that burned six months and runway after a vendor mishandled FHIR, HL7, and HIPAA requirements....
Practo, ZocDoc, Doctolib: Are a Wave of Healthcare Appointment Booking IPOs on the Horizon?
Health‑tech appointment‑booking firms are poised for a wave of multi‑billion‑dollar IPOs in 2026 as the sector shifts from pandemic‑era growth‑at‑all‑costs to durable, profit‑focused models. ZocDoc, Doctolib and India‑based Practo have all demonstrated profitability or clear paths to breakeven, while embedding...
Optum Real Partners with Microsoft to Accelerate Real‑time Healthcare Claims Processing
Optum Real and Microsoft announced a strategic partnership to build a cloud‑based, AI‑powered claims platform that processes submissions in near real time. Pilot results show an 80% drop in avoidable denials and a 75% reduction in reimbursement errors, promising faster...
ChristianaCare Names Jenn Schwartz CEO as Janice Nevin Retires Sept. 1
ChristianaCare will see Dr. Janice Nevin step down as president and CEO on Sept. 1 after a 12‑year tenure. The board has appointed executive vice president and chief strategy officer Jenn Schwartz as the new chief executive, positioning her to steer the...
Nanoz Unveils 2 Mm AI‑Powered Nanosensors for Health Diagnostics and Pollution Tracking
Nanoz, a French deep‑tech firm, launched 2‑mm AI‑powered nanosensors that identify complex gas signatures for medical diagnostics and environmental monitoring. The devices, built on metal‑oxide semiconductor technology, aim to bring non‑invasive breath tests and real‑time air‑quality data to markets worldwide.
SynuSight’s Α‑syn PET Tracer SST001 Cleared by China’s NMPA for Phase I Trial
Mabwell’s incubated unit SynuSight Biotech announced that the National Medical Products Administration approved its α‑synuclein PET tracer SST001 for a Phase I trial in China. The non‑randomized study will enroll healthy volunteers, Parkinson’s disease and multiple system atrophy patients at...
How Are Regulatory Factors Impacting Biosimilars
The FDA issued draft guidance in March that would drop certain pharmacokinetic (PK) studies for biosimilars, aiming to lower development costs. At the same time, the Inflation Reduction Act (IRA) and most‑favored‑nation (MFN) pricing provisions are reshaping how manufacturers price...
Why Genetic Diagnoses Take So Long for Kids
In this brief episode, host Catherine interviews the CEO of GeneDX about the stark delay—averaging five years—in diagnosing children with genetic diseases, despite the availability of rapid whole exome and genome sequencing that can deliver results in days. She explains...
The Spike, The Silence, and the System
In this episode, host Grant Stinchfield and Dr. Peter McCullough discuss a controversial CDC chart that appears to show a spike in U.S. deaths coinciding with the rollout of COVID‑19 vaccines in 2021, arguing the pattern suggests vaccine‑related mortality. They critique...
GlycoNex Secures Japan’s PMDA Approval for GNX1021 Phase I Trial
GlycoNex has secured approval from Japan’s Pharmaceuticals and Medical Devices Agency to launch a first‑in‑human Phase I study of its lead ADC, GNX1021, in advanced gastrointestinal cancers. The multi‑centre trial will begin patient enrollment in Japan by June 2026, with parallel IND...
Watch: AI and Preventative Health Webinar
Health Tech World and Femtech World hosted a webinar featuring four industry leaders discussing how artificial intelligence is transforming preventative health. The panel covered AI‑driven early disease detection, personalized lifestyle recommendations, and the specific implications for women’s health innovation. Recorded...
Blood Test Predicts Kidney Failure Risk to Black Americans Years Before Onset
University of Pennsylvania researchers have unveiled a blood‑based test that predicts kidney‑failure risk in individuals of African ancestry carrying high‑risk APOL1 gene variants. The assay measures a small panel of circulating proteins to generate a ten‑year risk score, distinguishing patients...
Loneliness Linked to Increased Risk of Degenerative Heart Valve Disease
A new cohort study of 463,000 UK Biobank participants found that adults who reported high levels of loneliness faced a 19% greater risk of developing degenerative heart valve disease, with even higher risks for aortic stenosis (21%) and mitral regurgitation...
A Molecular Movie Captures Cancer's Great Escape From Targeted Therapy
Researchers at the Institute for Systems Biology captured a "molecular movie" showing that melanoma cells enter a reversible, drug‑tolerant state within hours of BRAF‑targeted therapy. The study, published in Nature Communications, reveals an ordered two‑wave transcriptional program driven by NF‑κB‑mediated...
Printed Neurons Communicate with Living Brain Cells
Northwestern engineers have printed artificial neurons on flexible polymer using aerosol‑jet‑deposited MoS₂ and graphene inks. The devices generate complex, neuron‑like electrical spikes that successfully activate living mouse brain cells in tissue‑slice experiments. This low‑cost, biocompatible approach opens a path toward...
Medi-Cal Immigrant Enrollment Is Dropping. Researchers Point to Trump’s Policies.
Medi-Cal enrollment among undocumented immigrants in California has sharply declined, with roughly 100,000 leaving the program between June and December, accounting for a quarter of all disenrollments. Overall Medi-Cal enrollment fell about 1.6 million since its May 2023 peak, a reversal of...
They Counted on a Rural Dialysis Unit to Keep Them Alive. Then It Closed
Chadron Hospital, a critical‑access facility in western Nebraska, closed its outpatient dialysis unit after the service lost roughly $1 million annually due to low reimbursement rates. The shutdown affects 17 patients, forcing them to travel up to 1.5 hours each way or...
Quit a GLP-1? Plan to Start Again? It's Not Recommended, but Plenty of People Do It
GLP‑1 medications such as Ozempic and Zepbound are being prescribed widely for diabetes and obesity, yet adherence is low. A JAMA‑based analysis found fewer than one‑quarter of patients remain on a GLP‑1 after a year, and a Kantar survey shows...
AliveCor Launches “World First” Kardia 12L ECG in Europe
AliveCor secured CE Mark for its Kardia 12L, the world’s first AI‑powered, portable 12‑lead ECG system, and is launching it across major European markets. The device uses KAI 12L AI to detect 35 cardiac conditions, including acute myocardial infarction, from a single‑cable,...
“World’s Most Watched Surgeon” Publishes His Transformative Book Exploring the Future of AI in Healthcare
Renowned surgeon Prof Shafi Ahmed has launched his new book, INTELLIGENT: The Evolution of AI Transforming Healthcare, offering a deep dive into how artificial intelligence is reshaping medicine. Drawing on three decades of NHS practice and his reputation as the “world’s most...
Can Europe Finance and Keep Its Biotech Winners?
The United States saw a surge of life‑sciences IPOs in early 2026, raising over $1 billion, while Europe continues to lose its biotech firms to foreign markets. Over the past six years, 66 of 67 EU biotech companies that went public...
AI Identifies Early Risk Patterns for Skin Cancer
Swedish researchers used nationwide registry data from over 6 million adults to train AI models that predict melanoma risk. The most advanced model reached 73% accuracy, far above the 64% baseline of age‑sex only methods, and identified sub‑populations with a 33%...
Digital Health Systems Keep Failing. The Fix Isn’t More Tech, It’s Designing with and for People
Governments are pouring billions into digital health and civil registration systems, yet many remain underused because they were built without the people who operate them in mind. The Bloomberg Philanthropies Data for Health Global Grants Program found that human‑centered design...
STAT+: Flawed Study on the Antidepressant Paxil Came with a Cautionary Note — if You Knew How to Find It
The Journal of the American Academy of Child & Adolescent Psychiatry issued an expression of concern in late 2025 about a 2001 study that linked the antidepressant Paxil to outcomes in adolescents. The notice followed a formal request to retract...
Partner Therapeutics Reports the US FDA sBLA Submission of Bizengri for NRG1 Fusion Positive Cholangiocarcinoma
Partner Therapeutics has filed a supplemental Biologics License Application (sBLA) with the U.S. FDA for Bizengri (zenocutuzumab‑zbco), a monoclonal antibody designed for adults with advanced unresectable or metastatic cholangiocarcinoma that carry an NRG1 gene fusion. The filing is supported by...
Robotic Phlebotomy Achieves 94% Success, Low Complications
I've been following Vitestro for years. They have been developing robotic devices to collect patients' blood samples. They have big news now as the results of a multicenter ADOPT clinical trial have been published in Clinical Chemistry. That is the...
Doing This Throughout Life May Cut Alzheimer’s Risk by 38%
Researchers tracking 1,939 older adults over eight years found that individuals with the highest lifelong cognitive enrichment experienced a 38% lower risk of Alzheimer’s disease and a 36% lower risk of mild cognitive impairment. The top 10% of participants delayed...
24/7 GP Appointment Booking Is Now Live in the NHS App for More than One Million Patients
Rapid Health’s AI‑powered Smart Triage is now embedded in the NHS App, giving more than one million English patients 24‑hour, seven‑day access to GP appointments. The integration presents each user with an average of 61 available slots, with most selections...
Preparing Trust for Hospital Telemedicine Robots Amid Physician Shortages
Imagine being a physician sitting in front of a laptop webcam while roaming around in a hospital as a telemedicine robot. What a cultural shock it would be! But now North Carolina hospitals are deploying the OhmniCare Telehealth Robot to facilitate...
Boy Who Received Liver, Kidney Transplants From Parents Returns to School
A 12‑year‑old Taiwanese boy received a partial liver transplant from his mother in January 2025 and a living‑donor kidney transplant from his father in January 2026, making him National Taiwan University Hospital's first pediatric case of dual organ transplants within...
Lab Success Doesn't Guarantee Real Cancer Drug Efficacy
Just a reminder. Killing cancer cells in a lab is very easy. Almost anything will kill cells. Even water (because of osmotic damage). Inside our bodies killing cancer cells is extremely hard for many reasons so things that kill...
Know Critical Pediatric Emergency Signs Every Parent Needs
Are #parents missing life-threatening signs in their children? #Paediatric emergencies every parent must know. https://t.co/ayQmCxSvsZ #research #healthcare #parenting
The Best Non-Surgical Cosmetic Practitioners in 2026
Spear’s 2026 Non‑Surgical Cosmetics Index spotlights leading UK‑based practitioners renowned for clinical expertise, safety and natural‑looking outcomes. The list includes dermatologists, pharmacists and aesthetic doctors offering injectables, laser therapies, scalp treatments and hormone‑based solutions for high‑net‑worth (HNW) clients worldwide. Industry...
New Drug Boosts Survival for Platinum‑Resistant Ovarian Cancer
Combining a new drug with #chemotherapy extends the survival of platinum-resistant ovarian #cancer patients in #clinicaltrial https://t.co/JE4r8nISUq
Fatty Liver Affects 1.3B Now, 2B by 2050
1.3 Billion Globally Have Fatty Liver Disease; Numbers To Reach 2 Billion By 2050: Lancet Study https://t.co/DqKS8L0hCx #research #fattyliver #disease #health
PreVenTB Trial: Considerations for Interpreting Extrapulmonary Tuberculosis Efficacy and Tuberculin Skin Test-Stratified Analyses
The PreVenTB phase‑3 trial evaluated the recombinant BCG vaccine VPM1002 and the subunit vaccine Immuvac in 12,700 Indian household contacts, but neither met the primary endpoint of preventing microbiologically confirmed tuberculosis. The authors noted a 23.1% versus 20.3% six‑month tuberculin...
Hospice Staff to Call for £112m Funding Boost in Westminster Protest
Hospice staff across England are delivering a letter to the Prime Minister demanding a £112.5 million (≈$140 million) boost in recurring funding. Nearly 60% of hospices have already cut or plan to cut frontline services, leaving 380 beds idle and community visits...